←Back to Expert Scholars
Translational Medicine / 转化医学KRAS Inhibitors, Italian NSCLC Networks
Andrea Camerini
MD
🏢Versilia Hospital, Tuscany🌐Italy
Director of Medical Oncology
25
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Andrea Camerini leads medical oncology at a Tuscan hospital and runs real-world studies of KRAS G12C inhibitors in Italian NSCLC patients. His group focuses on elderly and frail populations. He contributes to AIOM guideline development.
Share:
🧪Research Fields 研究领域
NSCLC
KRAS G12C
elderly lung cancer
real-world evidence
precision oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Andrea Camerini 的研究动态
Follow Andrea Camerini's research updates
留下邮箱，当我们发布与 Andrea Camerini（Versilia Hospital, Tuscany）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment